Diversified Trust CO Supernus Pharmaceuticals, Inc. Transaction History

Diversified Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 09, 2019	SELL	$25.47 - $33.37 $164,281 - $215,236	-6,450 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$29.96 - $38.87 $14,980 - $19,435	500 Added 8.4%	6,450 $213,000
Q1 2019 May 22, 2019	BUY	$32.77 - $41.99 $194,981 - $249,840	5,950 New	5,950 $208,000
Q4 2018 Jan 18, 2019	SELL	$30.84 - $49.51 $149,574 - $240,123	-4,850 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$44.1 - $59.85 $11,025 - $14,962	250 Added 5.43%	4,850 $290,000
Q1 2018 Jun 01, 2018	BUY	$37.15 - $46.9 $170,890 - $215,740	4,600 New	4,600 $211,000

286

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.14B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.